Myriad Genetics, Inc.MYGNNASDAQ
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank86
3Y CAGR-4.6%
5Y CAGR+15.8%
Studio
Year-over-Year Change

Year-over-year debt growth rate

3Y CAGR
-4.6%/yr
vs -60.8%/yr prior
5Y CAGR
+15.8%/yr
Recent deceleration
Acceleration
+56.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202549.54%
2024-7.76%
20234.90%
202257.10%
2021-68.06%
202023.77%
20190.00%
20182410.75%
2017-90.62%
20160.00%